- Home
- KYMR vs CAMT Comparison
KYMR vs CAMT Comparison
Compare KYMR & CAMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- CAMT
- Stock Information
- Founded
- KYMR 2015
- CAMT 1987
- Country
- KYMR United States
- CAMT Israel
- Employees
- KYMR N/A
- CAMT N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- CAMT Electronic Components
- Sector
- KYMR Health Care
- CAMT Technology
- Exchange
- KYMR Nasdaq
- CAMT Nasdaq
- Market Cap
- KYMR 4.2B
- CAMT 3.8B
- IPO Year
- KYMR 2020
- CAMT 2000
- Fundamental
- Price
- KYMR $56.83
- CAMT $112.78
- Analyst Decision
- KYMR Strong Buy
- CAMT Strong Buy
- Analyst Count
- KYMR 17
- CAMT 11
- Target Price
- KYMR $61.65
- CAMT $96.91
- AVG Volume (30 Days)
- KYMR 910.5K
- CAMT 661.5K
- Earning Date
- KYMR 10-30-2025
- CAMT 11-11-2025
- Dividend Yield
- KYMR N/A
- CAMT 1.19%
- EPS Growth
- KYMR N/A
- CAMT 38.64
- EPS
- KYMR N/A
- CAMT 2.73
- Revenue
- KYMR $44,711,000.00
- CAMT $471,588,000.00
- Revenue This Year
- KYMR $62.11
- CAMT $17.22
- Revenue Next Year
- KYMR N/A
- CAMT $8.35
- P/E Ratio
- KYMR N/A
- CAMT $42.71
- Revenue Growth
- KYMR N/A
- CAMT 27.88
- 52 Week Low
- KYMR $19.45
- CAMT $47.41
- 52 Week High
- KYMR $59.00
- CAMT $119.27
- Technical
- Relative Strength Index (RSI)
- KYMR 65.68
- CAMT 65.44
- Support Level
- KYMR $54.09
- CAMT $113.02
- Resistance Level
- KYMR $59.00
- CAMT $119.26
- Average True Range (ATR)
- KYMR 2.39
- CAMT 5.40
- MACD
- KYMR 0.30
- CAMT 1.44
- Stochastic Oscillator
- KYMR 80.00
- CAMT 76.63
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About CAMT Camtek Ltd.
Camtek Ltd is engaged in the manufacturing of metrology and inspection equipment and software solutions for the semiconductor industry. Its systems inspect wafers for various semiconductor market segments, including Advanced Packaging, Heterogenous Integration (HI), Compound Semiconductors, Memory, and foundries among others. Geographically, it derives maximum revenue from China followed by Asia Pacific, Korea, United States, and Europe. The company's products and services include Surface Inspection, Bump Inspection and Metrology, and others.